Lifecore Biomedical, Inc.
LFCR
$6.04
-$0.365-5.70%
NASDAQ
| 02/23/2025 | 11/24/2024 | 08/25/2024 | 05/26/2024 | 02/25/2024 | |
|---|---|---|---|---|---|
| Net Income | -121.19% | 80.30% | 106.58% | 112.07% | 82.58% |
| Total Depreciation and Amortization | -3.02% | -16.34% | -28.35% | -39.32% | -33.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,046.79% | -78.79% | -126.86% | -133.43% | -97.62% |
| Change in Net Operating Assets | 194.34% | -131.06% | -7.38% | -118.14% | -105.12% |
| Cash from Operations | 128.79% | 102.23% | 131.89% | 101.04% | 31.83% |
| Capital Expenditure | 38.94% | 36.98% | 28.13% | 14.72% | 11.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | 101.81% |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 68.17% | -47.89% | -72.81% | -280.77% | -25.23% |
| Total Debt Issued | -19.15% | -13.83% | -16.98% | -17.56% | 441.39% |
| Total Debt Repaid | -8.71% | 11.02% | 17.22% | 17.33% | -307.19% |
| Issuance of Common Stock | 3,195.30% | 3,192.96% | -99.98% | -85.52% | -85.52% |
| Repurchase of Common Stock | -1,071.72% | -256.33% | -61.86% | 66.37% | 86.31% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -25.53% | 218.50% | 178.83% | 178.83% | 157.74% |
| Cash from Financing | -81.00% | -24.90% | -85.36% | -81.09% | -4.60% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,805.69% | 272.73% | -170.63% | -160.92% | -88.78% |